Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

APTNADAPTIN BIO, INC.

OTC · CIK 0001938571
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts152

Identity from submissions API

NameADAPTIN BIO, INC.
CIK0001938571
TickersAPTN
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN881566415
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(888) 609-1498
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Unite Acquisition 1 Corp. (2023-08-10T04:00:00.000Z → 2025-02-13T05:00:00.000Z)
Business address
3540 TORINGDON WAY
SUITE 200, #250
CHARLOTTE
NC
28277
NC
Mailing address
3540 TORINGDON WAY
SUITE 200, #250
CHARLOTTE
NC
28277
NC

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

78 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-17 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-121396 333-298622 261566073 33 436854
2026-11-17 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-121395 333-287338 261566071 33 436778
2026-11-13 10-Q QUARTERLY REPORT 0001213900-26-119688 000-56583 261552413 34 4453857 1 1
2026-09-10 424B3 PROSPECTUS 0001213900-26-098801 333-298622 261371279 33 1552147
2026-09-09 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002923 333-298622 261370093 33 1877
2026-08-28 S-1 REGISTRATION STATEMENT 0001213900-26-095034 333-298622 261339981 33 12721560 1 1
2026-08-25 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-093549 333-287338 261316328 33 47795
2026-08-25 8-K CURRENT REPORT 8.01,9.01 0001213900-26-093520 000-56583 261315812 34 209790 1 1
2026-08-20 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-092107 333-287338 261299983 33 488304
2026-08-13 10-Q QUARTERLY REPORT 0001213900-26-089081 000-56583 261273204 34 4416994 1 1
2026-07-22 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002384 333-287338 261195063 33 1890
2026-07-21 POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 0001213900-26-080096 333-287338 261190985 33 7415077 1 1
2026-06-22 D/A xslFormDX01/primary_doc.xml 06b 0001938571-26-000004 021-568890 261107640 33 13933
2026-06-12 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-068357 333-287338 261087745 33 113176
2026-06-12 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001213900-26-068261 000-56583 261086569 34 263115 1 1
2026-05-18 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-058479 333-287338 26993987 33 1701077
2026-05-15 10-Q QUARTERLY REPORT 0001213900-26-057188 000-56583 26982782 34 3709609 1 1
2026-04-06 8-K CURRENT REPORT 8.01,9.01 0001213900-26-040458 000-56583 26841188 34 199335 1 1
2026-04-01 10-K ANNUAL REPORT 0001213900-26-038568 000-56583 26828871 34 5900917 1 1
2026-04-01 NT 10-K NOTIFICATION OF LATE FILING 0001213900-26-038402 000-56583 26827092 34 20636
2026-03-23 D/A xslFormDX01/primary_doc.xml 06b 0001938571-26-000003 021-568890 26781489 33 13838
2026-02-20 D/A xslFormDX01/primary_doc.xml 06b 0001938571-26-000002 021-568890 26658696 33 13742
2026-01-05 D xslFormDX01/primary_doc.xml 06b 0001938571-26-000001 021-568890 26506111 33 13363
2025-12-23 8-K CURRENT REPORT 1.01,3.02 0001213900-25-125451 000-56583 251601623 34 193929 1 1
2025-11-17 424B3 PROSPECTUS SUPPLEMENT 0001213900-25-111384 333-287338 251490129 33 519315
2025-11-14 10-Q QUARTERLY REPORT 0001213900-25-110559 000-56583 251483651 34 3981895 1 1
2025-10-07 424B3 PROSPECTUS SUPPLEMENT 0001213900-25-097028 333-287338 251379855 33 65945
2025-10-06 8-K CURRENT REPORT 5.02,8.01,9.01 0001213900-25-096532 000-56583 251376905 34 230188 1 1
2025-09-10 4 PRIMARY DOCUMENT 0001213900-25-086588 5543
2025-09-10 4 PRIMARY DOCUMENT 0001213900-25-086586 5588
2025-09-10 4 PRIMARY DOCUMENT 0001213900-25-086585 5560
2025-09-10 4 PRIMARY DOCUMENT 0001213900-25-086583 6189
2025-09-10 4 PRIMARY DOCUMENT 0001213900-25-086582 6170
2025-09-10 4 PRIMARY DOCUMENT 0001213900-25-086581 5688
2025-09-10 4 PRIMARY DOCUMENT 0001213900-25-086580 5630
2025-08-15 S-8 REGISTRATION STATEMENT 0001213900-25-077209 333-289627 251223519 33 194234 1 1
2025-08-15 424B3 424B3 0001213900-25-077176 333-287338 251223279 33 403609
2025-08-14 10-Q QUARTERLY REPORT 0001213900-25-076361 000-56583 251216722 34 2971298 1 1
2025-08-05 424B3 PROSPECTUS 0001213900-25-071970 333-287338 251184304 33 1946842
2025-08-04 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002464 333-287338 251182584 33 1877
2025-07-31 CORRESP filename1.htm 0001213900-25-069774 7425
2025-07-28 CORRESP filename1.htm 0001213900-25-068142 26130
2025-07-28 S-1/A AMENDMENT NO. 2 TO FORM S-1 0001213900-25-068130 333-287338 251155202 33 6456528 1 1
2025-07-16 UPLOAD filename1.pdf 0000000000-25-007475 333-287338 45459
2025-06-27 CORRESP filename1.htm 0001213900-25-058971 93347
2025-06-27 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-25-058957 333-287338 251085846 33 9838574 1 1
2025-06-13 UPLOAD filename1.pdf 0000000000-25-006275 333-287338 58665
2025-05-16 S-1 REGISTRATION STATEMENT 0001213900-25-044585 333-287338 25956872 33 5958079 1 1
2025-05-15 10-Q QUARTERLY REPORT 0001213900-25-044083 000-56583 25951734 34 2955649 1 1
2025-04-15 10-K ANNUAL REPORT 0001213900-25-031878 000-56583 25838618 34 3311960 1 1
2025-04-15 8-K/A AMENDMENT NO. 1 TO FORM 8-K 2.01,9.01 0001213900-25-031875 000-56583 25838600 34 659619 1 1
2025-04-09 8-K CURRENT REPORT 8.01,9.01 0001213900-25-030320 000-56583 25825551 34 214560 1 1
2025-03-31 NT 10-K NOTIFICATION OF LATE FILING 0001213900-25-026302 000-56583 25793759 34 24063
2025-02-26 D xslFormDX01/primary_doc.xml 06b 0001578563-25-000148 021-539301 25669510 33 15440
2025-02-18 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-014978 005-94821 25636658 34 10062
2025-02-18 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-014977 005-94821 25636647 34 9943
2025-02-18 3 PRIMARY DOCUMENT 0001213900-25-014974 6525
2025-02-18 3 PRIMARY DOCUMENT 0001213900-25-014973 7143
2025-02-18 3 PRIMARY DOCUMENT 0001213900-25-014971 6502
2025-02-18 3 PRIMARY DOCUMENT 0001213900-25-014970 7085
2025-02-18 3 PRIMARY DOCUMENT 0001213900-25-014969 6585
2025-02-18 3 PRIMARY DOCUMENT 0001213900-25-014968 6526
2025-02-18 3 PRIMARY DOCUMENT 0001213900-25-014967 6580
2025-02-18 8-K CURRENT REPORT 1.01,2.01,3.02,3.03,4.01,5.01,5.02,5.03,5.05,5.06,9.01 0001213900-25-014630 000-56583 25633035 34 5670293 1 1
2025-02-13 4 xslF345X05/ownership.xml 0001213900-25-013732 5401
2025-01-29 SC 14F1 SCHEDULE 14F-1 0001213900-25-007939 005-94821 25570399 34 116289
2024-11-14 10-Q QUARTERLY REPORT 0001213900-24-098361 000-56583 241461233 34 1550600 1 1
2024-08-14 10-Q QUARTERLY REPORT 0001213900-24-068816 000-56583 241206221 34 1559089 1 1
2024-05-15 10-Q QUARTERLY REPORT 0001213900-24-043492 000-56583 24949668 34 1384811 1 1
2024-04-01 10-K ANNUAL REPORT 0001213900-24-028681 000-56583 24808924 34 1995533 1 1
2023-11-30 3 xslF345X02/ownership.xml 0001213900-23-091523 2864
2023-11-30 3 xslF345X02/ownership.xml 0001213900-23-091517 3963
2023-11-20 UPLOAD filename1.pdf 0000000000-23-012676 39831
2023-11-14 10-Q QUARTERLY REPORT 0001213900-23-086982 000-56583 231406715 34 1334191 1 1
2023-10-06 CORRESP filename1.htm 0001013762-23-002586 47081
2023-10-06 10-12G/A AMENDMENT NO.1 TO FORM 10-12G 0001013762-23-002582 000-56583 231315011 34 298666
2023-09-07 UPLOAD filename1.pdf 0000000000-23-009873 51259
2023-08-10 10-12G GENERAL FORM FOR REGISTRATION OF SECURITIES 0001213900-23-065715 000-56583 231160741 34 435419

Latest XBRL company facts

One latest value per concept from companyfacts (152 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 9.26M 2026-11-12 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
dei EntityPublicFloat Entity Public Float USD 9.30M 2025-06-30 2025 FY 10-K/A 2026-06-12 0001213900-26-068261
ffd NetFeeAmt NetFeeAmt USD 364.23 2026-08-25 S-1 2026-08-28 0001213900-26-095034
ffd TtlFeeAmt TtlFeeAmt USD 364.23 2026-08-25 S-1 2026-08-28 0001213900-26-095034
ffd TtlOfferingAmt TtlOfferingAmt USD 2.64M 2026-08-25 S-1 2026-08-28 0001213900-26-095034
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-25 S-1 2026-08-28 0001213900-26-095034
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-25 S-1 2026-08-28 0001213900-26-095034
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 5,890 2024-12-31 2024 FY 10-K 2025-04-15 0001213900-25-031878
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.69M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap AccountsPayableOtherCurrentAndNoncurrent Accounts Payable, Other USD 313,850 2024-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 990,185 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 15,460 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 25,000 2025-12-31 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 10.93M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 36,435 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 496,864 2025-01-01 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 53,722 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 2.58M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001213900-25-110559
us-gaap Assets Assets USD 1.09M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap AssetsCurrent Assets, Current USD 1.09M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 1.68M 2026-01-01 2026-06-30 S-1 2026-08-28 0001213900-26-095034
us-gaap Cash Cash USD 1.35M 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076361
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 430,333 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 430,333 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -28,841 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2024-12-31 2024 FY 10-K 2025-04-15 0001213900-25-031878
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 4.96 2025-09-30 2025 Q3 10-Q 2025-11-14 0001213900-25-110559
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 132,570 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 2.61M 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 1.48M 2025-09-30 2025 Q3 10-Q 2025-11-14 0001213900-25-110559
us-gaap CommonStockConvertibleConversionPriceIncrease Common Stock, Convertible, Conversion Price, Increase USD/shares 3.3 2026-01-01 2026-06-30 S-1 2026-08-28 0001213900-26-095034
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 50.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 9.26M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 9.26M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap CommonStockValue Common Stock, Value, Issued USD 926 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 501,140 2026-01-01 2026-06-30 S-1 2026-08-28 0001213900-26-095034
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 1.25M 2024-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap CostsAndExpensesRelatedParty Costs and Expenses, Related Party USD 3,750 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098361
us-gaap DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 Debt Conversion, Converted Instrument, Warrants or Options Issued shares 132,570 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044083
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 193,876 2024-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap DeferredFinanceCostsGross Debt Issuance Costs, Gross USD 197,570 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNet Deferred Finance Costs, Own-share Lending Arrangement, Issuance Costs, Net USD 193,876 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 2.02M 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 236,213 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 1.67M 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 85,817 2024-12-31 2024 FY 10-K 2025-04-15 0001213900-25-031878
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 6,879 2023-12-31 2024 FY 10-K 2025-04-15 0001213900-25-031878
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 113,173 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 3,127 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028681
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 6,879 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028681
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 2.02M 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 31.00M 2025-09-30 2025 Q3 10-Q 2025-11-14 0001213900-25-110559
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD -6,312 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap DerivativeLiabilities Derivative Liability USD 551,269 2026-06-30 S-1 2026-08-28 0001213900-26-095034
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 544,957 2024-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.37 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.37 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.243 2025-01-01 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0.018 2024-01-01 2024-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.008 2025-01-01 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.102 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001213900-25-031878
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure 0.8 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028681
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 1.02M 2025-01-01 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 2.20M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 6,312 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap FederalDepositInsuranceCorporationPremiumExpense Federal Deposit Insurance Corporation Premium Expense USD 250,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043492
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 326,345 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 2.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -3.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2025-01-01 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 58 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001213900-25-031878
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 1.11M 2025-01-01 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -1.09M 2025-01-01 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 55,270 2024-01-01 2024-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 40,334 2025-01-01 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -453,445 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038568
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 161,293 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 393,720 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD -32,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001213900-25-031878
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 14,190 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap IncreaseDecreaseInNotesPayableCurrent Increase (Decrease) in Notes Payable, Current USD 22,568 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001213900-23-086982
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 148,531 2025-01-01 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 230,838 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap InterestExpenseDebt Interest Expense, Debt USD 9,605 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 9,605 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 9,605 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap InterestPayableCurrent Interest Payable, Current USD 134,875 2024-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 250,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap Liabilities Liabilities USD 2.76M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.09M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap LiabilitiesCurrent Liabilities, Current USD 2.76M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 1.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -2.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -3.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap NoncashOrPartNoncashAcquisitionPayablesAssumed1 Noncash or Part Noncash Acquisition, Payables Assumed USD 80,915 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028681
us-gaap NoninterestExpenseDirectorsFees Noninterest Expense Directors Fees USD 9,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098361
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -9,605 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap NotesPayable Notes Payable USD 81,219 2024-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043492
us-gaap NotesPayableCurrent Notes Payable, Current USD 81,219 2023-12-31 2024 FY 10-K 2025-04-15 0001213900-25-031878
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001213900-25-031878
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001213900-25-031878
us-gaap OperatingExpenses Operating Expenses USD 3.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -3.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 12,576 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044083
us-gaap OtherExpenses Other Expenses USD 31,353 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068816
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 180,000 2025-01-01 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap OtherNotesPayableCurrent Other Notes Payable, Current USD 275,000 2024-12-31 2024 FY 10-K 2025-04-15 0001213900-25-031878
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 12,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 1.46M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044083
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 127,510 2024-01-01 2024-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 215,746 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 657,307 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 404,808 2026-03-31 POS AM 2026-07-21 0001213900-26-080096
us-gaap PrepaidInsurance Prepaid Insurance USD 216,020 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 912,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 6.16M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 582,961 2025-12-22 S-1 2026-08-28 0001213900-26-095034
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 1.00M 2024-01-01 2024-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD -139,172 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001213900-25-031878
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 1.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 275,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 419,700 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -12.60M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 4 2025-10-29 S-1 2026-08-28 0001213900-26-095034
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 52,000 2026-06-09 S-1 2026-08-28 0001213900-26-095034
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 723,561 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage pure 0.25 2025-01-01 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.823 2026-01-01 2026-03-31 POS AM 2026-07-21 0001213900-26-080096
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.039 2026-01-01 2026-03-31 POS AM 2026-07-21 0001213900-26-080096
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 164,770 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001213900-25-110559
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 3.53 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 109,846 2026-06-30 S-1 2026-08-28 0001213900-26-095034
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -1.67M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 250,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 202,621 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 184,359 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 801,309 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 112,155 2025-12-31 S-1 2026-08-28 0001213900-26-095034
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 50,387 2024-12-31 2024 FY 10-K 2025-04-15 0001213900-25-031878
us-gaap WarrantExercisePriceDecrease Warrant, Exercise Price, Decrease USD/shares 3.3 2026-01-01 2026-06-30 S-1 2026-08-28 0001213900-26-095034
us-gaap WarrantExercisePriceIncrease Warrant, Exercise Price, Increase USD/shares 4.4 2026-01-01 2026-06-30 S-1 2026-08-28 0001213900-26-095034
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 2.58M 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044083
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 8.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 8.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119688

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →